54gene has unveiled its new lab in Lagos State, Nigeria, capable of human whole-genome sequencing and a variety of other scientific investigations. Hosting a suite of world-class molecular genomics capabilities, including the Illumina Novaseq 6000 and NextSeq 550Dx the lab is part of 54gene’s mission to enable Africans to conduct genomics research and will be fully operational from January 2021. The new lab, recently inspected by the Commissioner of Health for Lagos State, Prof. Akin Abayomi, is geared to crucially expedite internal and external research projects designed to facilitate precision medicine for Africans and the global population.
54gene is currently conducting research to discover novel biological insights based on genetic modifiers, by deriving information from its unique and rich data set. This will allow the company’s researchers to determine the underlying drivers of infectious and non-communicable diseases prevalent on the African continent as well as genetic variants unique to its population. The new lab strengthens 54gene’s capacity to enable more research that yields insights from the world’s most diverse populations to solve some of the biggest global healthcare challenges.